Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Oi, H. [1 ]
Taniguchi, H. [1 ]
Kondoh, Y. [1 ]
Kimura, T. [1 ]
Kataoka, K. [1 ]
Matsuda, T. [1 ]
Yokoyama, T. [1 ]
机构：
[1] Tosei Gen Hosp, Resp Med & Allergy, Seto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Advanced Non-Small Cell Lung Cancer; interstitial lung disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-037
引用
收藏
页码：S2082 / S2082
页数：1
相关论文
共 50 条
  • [21] Management of Oligometastatic Disease in Advanced Non-Small Cell Lung Cancer
    West, Howard
    [J]. CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 249 - +
  • [22] Clinical impact of lung age on postoperative readmission in non-small cell lung cancer
    Ogawa, Fumihiro
    Satoh, Yukitoshi
    Iyoda, Akira
    Amano, Hideki
    Kumagai, Yuji
    Majima, Masataka
    [J]. JOURNAL OF SURGICAL RESEARCH, 2015, 193 (01) : 442 - 448
  • [23] Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer
    Wang, Yanning
    Gong, Xiaoling
    Hu, Yuxuan
    Yi, Qing
    Zhang, Qianning
    Miao, Liyun
    Zhou, Yujie
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] IMPACT OF SPONSOR ON ADVANCED NON-SMALL CELL LUNG CANCER CLINICAL TRIAL ENROLLMENT CRITERIA
    Cooper, R. A.
    Chai, Y.
    Nieva, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 163 - 164
  • [25] Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
    Shi, Liang
    Tang, Junfang
    Tong, Li
    Liu, Zhe
    [J]. LUNG CANCER, 2014, 83 (02) : 231 - 239
  • [26] Vinorelbine and Cisplatin in Patients with Advanced Non-small Cell Lung Cancer with Interstitial Pneumonia
    Watanabe, Naohiro
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    [J]. ANTICANCER RESEARCH, 2015, 35 (03) : 1697 - 1701
  • [27] Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease
    Tasaka, Yuri
    Honda, Takayuki
    Nishiyama, Naoki
    Tsutsui, Toshiharu
    Saito, Hiroaki
    Watabe, Haruna
    Shimaya, Kazuhiro
    Mochizuki, Akifumi
    Tsuyuki, Shun
    Kawahara, Tatsuo
    Sakakibara, Rie
    Mitsumura, Takahiro
    Okamoto, Tsukasa
    Kobayashi, Masayoshi
    Chiaki, Tomoshige
    Yamashita, Takaaki
    Tsukada, Yoshikazu
    Taki, Reiko
    Jin, Yasuto
    Sakashita, Hiroyuki
    Natsume, Ichirou
    Saitou, Kazuhito
    Miyashita, Yoshihiro
    Miyazaki, Yasunari
    [J]. LUNG CANCER, 2021, 155 : 120 - 126
  • [28] Chemotherapy of Advanced Non-Small Cell Lung Cancer
    Pirker, Robert
    Minar, Wilma
    [J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 157 - 163
  • [29] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
  • [30] Chemotherapy in advanced non-small cell lung cancer
    Evans, T
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 304 - 313
12345